BOSTON, Nov 6 (Reuters) - Ironwood Pharmaceuticals IRWD.O on Friday handed a board seat to activist investor Sarissa Capital Management, at a time when shareholders are restless about the company's ...

Activist investor Alex Denner is back at it in biopharma. Just a few months after playing a pivotal role in Sanofi’s Bioverativ acquisition, he has set his sights on Ironwood Pharmaceuticals. The ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Alexander Denner, Ph.D., to its Board of Directors, effective November 9, 2020. Dr. Denner is ...

Ironwood’s activist investor likes what it’s seen recently from the drugmaker—so much so that it held off on pushing for a spot on the company's board. On Thursday, Sarissa Capital, the fund run by ...

The vote ends a proxy battle at one of the largest drug companies in Massachusetts. Ironwood Pharmaceuticals shareholders have rejected an attempt by activist investor Alex Denner to join the ...

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital Management, a Greenwich-based ...

Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD. Before ...

BOSTON, Nov 6 (Reuters) - Ironwood Pharmaceuticals on Friday handed a board seat to Sarissa Capital Management, sparking its shares to surge as much as 14% when the activist investor secured the spot ...

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. I can’t say whether Denner was the first activist healthcare investor, but he ...

BOSTON, Nov 6 (Reuters) - Ironwood Pharmaceuticals IRWD.O on Friday handed a board seat to Sarissa Capital Management, sparking its shares to surge as much as 14% when the activist investor secured ...